​

GeneDx Ownership | Who Owns GeneDx?

OverviewForecastRevenueFinancialsChartTranscripts

GeneDx Ownership Summary

GeneDx is owned by 109.56% institutional investors, 12.46% insiders. Casdin capital is the largest institutional shareholder, holding 12.27% of WGS shares.

WGS Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockGeneDx109.56%12.46%-22.02%
SectorHealthcare Stocks 487.91%11.08%-398.99%
IndustryHealthcare Information Services Stocks 54.77%12.92%32.31%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Casdin capital3.51M12.27%$323.75M
Corvex management lp3.06M10.70%$282.34M
William blair investment management1.63M5.71%$150.59M
Blackrock funding, inc. /de1.43M5.02%$132.43M
Pentwater capital management lp1.22M4.27%$112.62M
Goldman sachs group1.14M4.22%$87.89M
Vanguard group1.01M3.71%$77.34M
T. rowe price investment management1.04M3.63%$95.74M
Oracle investment management922.45K3.23%$85.15M
Fred alger management820.52K2.87%$75.74M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Oracle investment management922.45K58.40%$85.15M
Casdin capital3.51M29.48%$323.75M
Corvex management lp3.06M11.95%$282.34M
Gagnon advisors127.06K7.88%$11.73M
Zweig-dimenna associates586.10K5.12%$54.10M
Gagnon securities271.23K5.09%$25.04M
Palisades investment partners82.97K3.35%$7.66M
Legal advantage investments60.65K2.94%$6.53M
Tri locum partners lp127.57K2.03%$9.80M
Options solutions69.86K1.92%$6.45M

Top Buyers

HolderShares% AssetsChange
Pentwater capital management lp1.22M0.73%1.19M
Corvex management lp3.06M11.95%584.85K
T. rowe price investment management1.04M0.06%533.38K
William blair investment management1.63M0.40%442.41K
Jennison associates397.90K0.02%391.54K

Top Sellers

HolderShares% AssetsChange
Millennium management58.80K0.00%-515.63K
Summit partners public asset management767.26K1.79%-435.26K
Blackstone---420.71K
American century companies---269.60K
Point72 asset management52.55K0.01%-234.42K

New Positions

HolderShares% AssetsChangeValue
Macquarie group384.48K0.04%384.48K$29.55M
Sumitomo mitsui trust292.25K0.02%292.25K$31.49M
Massachusetts financial services co /ma/235.09K0.01%235.09K$21.70M
Parkman healthcare partners175.00K1.86%175.00K$16.15M
Portolan capital management162.23K0.94%162.23K$14.98M

Sold Out

HolderChange
Mather group, llc.-2.00
Parallel advisors-3.00
Allworth financial lp-5.00
Org partners-5.00
Northwestern mutual wealth management-7.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20252481.64%31,311,68210.33%1091.08%146-0.68%60-1.64%
Mar 31, 202524215.24%28,417,95020.78%1001.34%144-4.64%6272.22%
Dec 31, 202419836.55%21,822,46915.86%801.67%14145.36%3332.00%
Sep 30, 202414557.61%18,835,00115.66%691.86%9746.97%25127.27%
Jun 30, 20249250.82%16,284,87717.09%612.15%6688.57%1137.50%

Recent Insider Transactions

DateNameRoleActivityValue
Sep 30, 2025Stueland Katherine CHIEF EXECUTIVE OFFICERSell$560.46K
Sep 30, 2025Stueland Katherine CHIEF EXECUTIVE OFFICERSell$480.16K
Sep 30, 2025Stueland Katherine CHIEF EXECUTIVE OFFICERSell$116.51K
Sep 30, 2025Stueland Katherine CHIEF EXECUTIVE OFFICERSell$63.69K
Sep 30, 2025Stueland Katherine CHIEF EXECUTIVE OFFICERSell$60.46K

Insider Transactions Trends

DateBuySell
2025 Q3-39
2025 Q2537
2025 Q1-30
2024 Q4-38
2024 Q3-26

WGS Ownership FAQ

Who Owns GeneDx?

GeneDx shareholders are primarily institutional investors at 109.56%, followed by 12.46% insiders and -22.02% retail investors. The average institutional ownership in GeneDx's industry, Healthcare Information Services Stocks , is 54.77%, which GeneDx exceeds.

Who owns the most shares of GeneDx?

GeneDx’s largest shareholders are Casdin capital (3.51M shares, 12.27%), Corvex management lp (3.06M shares, 10.70%), and William blair investment management (1.63M shares, 5.71%). Together, they hold 28.68% of GeneDx’s total shares outstanding.

Does Blackrock own GeneDx?

BlackRock is not among the top 10 institutional shareholders of GeneDx.

Who is GeneDx’s biggest shareholder by percentage of total assets invested?

Oracle investment management is GeneDx’s biggest shareholder by percentage of total assets invested, with 58.40% of its assets in 922.45K GeneDx shares, valued at 85.15M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools